WallStSmart
ALXO

Alx Oncology Holdings 

NASDAQ: ALXO · HEALTHCARE · BIOTECHNOLOGY

$1.70
+7.59% today

Updated 2026-04-30

Market cap
$224.72M
P/E ratio
P/S ratio
5,085.96x
EPS (TTM)
$-1.90
Dividend yield
52W range
$0 – $3
Volume
1.0M

Alx Oncology Holdings  (ALXO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-21.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+16.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+7.6%
2025-11-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-05$-0.37-4.9%$2.19$2.21+0.9%
2025-11-07$-0.41-10.8%$1.18$1.27+7.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.35$-0.37-4.9%
2025-09-30$-0.37$-0.41-10.8%
2025-06-30$-0.43$-0.49-14.0%
2025-03-31$-0.31$-0.48-54.5%
2024-12-31$-0.39$-0.44-12.8%$868000.00-65.0%
2024-09-30$-0.78$-0.58+25.6%
2024-06-30$-0.77$-0.76+1.3%
2024-03-31$-0.84$-0.71+15.5%
2023-12-31$-0.84$-0.93-10.7%$2.48M
2023-09-30$-0.87$-1.24-42.5%
2023-06-30$-0.88$-0.84+4.5%
2023-03-31$-0.80$-0.74+7.5%
2022-12-31$-0.89$-0.75+15.7%

Frequently asked questions

Has Alx Oncology Holdings  beaten earnings estimates?
Alx Oncology Holdings  has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -21.0% over the last 4 quarters.
How does ALXO stock react to earnings?
ALXO stock has moved an average of +4.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.